SMAD4 and prostate carcinoma: Given the variety of tumor suppressor genes and oncogenes manipulated to model prostate cancer using the PB-Cre4 driver, it is remarkable that concurrent inactivation of Smad4 and Apc were the only reported genetic changes sufficient to drive oncogenesis of mouse penile epithelium.